0001140361-18-004481.txt : 20180201 0001140361-18-004481.hdr.sgml : 20180201 20180201164817 ACCESSION NUMBER: 0001140361-18-004481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180130 FILED AS OF DATE: 20180201 DATE AS OF CHANGE: 20180201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PHASE4 VENTURES III LP CENTRAL INDEX KEY: 0001687344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 18567445 BUSINESS ADDRESS: STREET 1: C/O PHASE4 PARTNERS LIMITED STREET 2: 50 LOTHIAN ROAD, FESTIVAL SQUARE CITY: EDINBURGH STATE: X0 ZIP: EH39WJ BUSINESS PHONE: 617-415-4774 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA, INC. STREET 2: 50 MILK STREET, 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PHASE4 VENTURES III GENERAL PARTNER Ltd CENTRAL INDEX KEY: 0001687418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 18567446 BUSINESS ADDRESS: STREET 1: C/O PHASE4 PARTNERS LIMITED STREET 2: 50 LOTHIAN ROAD, FESTIVAL SQUARE CITY: EDINBURGH STATE: X0 ZIP: EH39WJ BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA, INC. STREET 2: 50 MILK STREET, 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER NAME: FORMER CONFORMED NAME: PHASE4 GENERAL PARTNER Ltd DATE OF NAME CHANGE: 20161013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Phase4 Partners Ltd CENTRAL INDEX KEY: 0001600023 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 18567447 BUSINESS ADDRESS: STREET 1: GREEN PARK HOUSE STREET 2: 15 STRATTON STREET CITY: LONDON STATE: X0 ZIP: W1J 8LQ BUSINESS PHONE: 44 0 20 3036 0050 MAIL ADDRESS: STREET 1: GREEN PARK HOUSE STREET 2: 15 STRATTON STREET CITY: LONDON STATE: X0 ZIP: W1J 8LQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 form4.xml FORM 4 X0306 4 2018-01-30 true 0001322505 ALBIREO PHARMA, INC. ALBO 0001600023 Phase4 Partners Ltd 1 CAVENDISH PLACE LONDON X0 W1G 0QF UNITED KINGDOM true 0001687418 PHASE4 VENTURES III GENERAL PARTNER Ltd 50 LOTHIAN ROAD, FESTIVAL SQUARE EDINBURGH X0 EH3 9WJ UNITED KINGDOM true 0001687344 PHASE4 VENTURES III LP 1 CAVENDISH PLACE LONDON X0 W1G 0QF UNITED KINGDOM true Common Stock 2018-01-30 4 S 0 98500 34.4006 D 1066947 I Held by Phase4 Ventures III GP LP Common Stock 2018-01-30 4 S 0 1500 37.0587 D 1065447 I Held by Phase4 Ventures III GP LP The number of securities reported represents an aggregate number of shares sold in multiple market transactions over a range of sale prices. The Reporting Persons undertake to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Persons at each separate price within the range. Sale prices range from $34.40 to $34.71, inclusive. Sale prices range from $36.60 to $37.43, inclusive. Consists of shares held by Phase4 Ventures III GP LP ("Phase4 GPLP") in its capacity as general partner of Phase4 Ventures III LP ("Phase4 III"). Phase4 GPLP is the general partner of Phase4 III. The general partner of Phase4 GPLP is Phase 4 Ventures III General Partner Limited ("Phase4 GP"). Phase4 GP has appointed Phase4 Partners Limited ("Phase4 Partners") to act as the manager of Phase4 III. Dr. Alastair McKinnon, Denise Scots-Knight, PhD, and Charles Sermon are Directors of Phase4 Partners (the "Phase4 Directors"). Each of the Phase4 Directors, Phase4 Partners, Phase4 GP, Phase 4 GPLP and Phase4 III may be deemed to beneficially own the shares held by Phase4 GPLP in its capacity as general partner of Phase4 III, but disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. /s/ Charles Sermon, Director, Phase4 Partners Limited 2018-02-01 /s/ Charles Sermon, Director, Phase4 Ventures III General Partner Limited 2018-02-01 /s/ Charles Sermon, Director, Phase4 Ventures III LP 2018-02-01